TGF- β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization
Conclusion: Our study demonstrated that the TGF-β-acetylated KLF5-Bcl-2 signaling axis mediates DTX resistance in prostate cancer and blockade of this pathway could provide clinical insights into chemoresistance of prostate cancer.
Source: Theranostics - Category: Molecular Biology Authors: Yixiang Li, Baotong Zhang, Lingwei Xiang, Siyuan Xia, Omer Kucuk, Xingming Deng, Lawrence H. Boise, Jin-Tang Dong Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Docetaxel | Genetics | Hormone Refractory Prostate Cancer | Hormones | Legislation | Molecular Biology | Prostate Cancer | Study | Taxotere | USA Health